BXP Reports Q3 Results as Shorts Hold and Options Stay Bullish

BXP has just released its Q3 results today, and the data heading into the print told a story of two camps: short sellers adding conviction while options traders leaned the other way.

Short interest built steadily through October and is now at 7.84% of the free float, up roughly 8% on the week and close to 8% over the past month, with the position sitting near 12.4 million shares. That is a meaningful level for an office REIT mid-recovery. The FINRA-reported days-to-cover reading of 8.9 days means any forced unwind would be slow. But the borrow market offers no squeeze catalyst. Availability remains generous at 589%, nearly six shares available in the lending pool for every one borrowed, and the cost to borrow is a nominal 0.48%. The ORTEX short score has crept higher this week to 58.1, a modest rise from 56.5 two weeks ago, consistent with shorts adding but not yet at a level that signals extreme bearish crowding.

Options positioning pulled in the opposite direction. The put/call ratio hit 0.76 on Tuesday, almost 1.8 standard deviations below its 20-day average of 0.91. That is the lightest put demand relative to calls since mid-September, when the ratio was close to its 52-week low of 0.39. Options traders, in other words, were buying into the print rather than hedging against it. The contrast between a rebuilding short book and rising call demand is the clearest tension in this week's setup: one set of market participants positioned for disappointment, the other for a beat.

The Street sits cautiously constructive. Evercore ISI raised its target by a dollar to $66 this morning, maintaining an In-Line rating, the smallest of nudges. Before that, Piper Sandler cut its target sharply from $88 to $72 in mid-October while keeping an Overweight. JPMorgan and Wells Fargo lifted targets over the summer and remain bullish, with JPMorgan at $87. The mean target across the Street is $73.35 against a current price of $60.89, implying roughly 20% upside in aggregate. The bull case centres on improving leasing momentum, occupancy heading toward 91%, and demand from AI tenants in San Francisco and New York. The bear case is simpler: the portfolio is heavily concentrated in cyclical office markets, leverage is a drag, and any softening in office-using employment unwinds the recovery thesis. EPS momentum over 30 days ranks in just the 9th percentile, though the 90-day window is a more comfortable 62nd, suggesting near-term estimates have been coming in softer.

On the institutional register, Cohen & Steers remains the largest holder with a 14.3% stake, and its August filing showed the position growing. BlackRock added over 1.5 million shares in the period ending September 30. Norges Bank moved the other way, trimming its stake from 6.4% to 4.1% as disclosed in its August filing. No 13D activist is on the register, and all large positions are passive Schedule 13G filings. Insider activity has been quiet since June, when CFO Michael LaBelle sold just over $1.7 million in shares across two transactions. Neither sale was under a 10b5-1 plan, but no buying has followed since.

Wikipedia attention for BXP is running at a z-score of 3.0 against its own 90-day history as of October 22, an elevated retail attention reading that likely reflects earnings anticipation rather than any fundamental shift. The next scheduled earnings event is now January 26, 2027. With the Q3 print now out, the focus shifts to management's tone on leasing pipeline, occupancy trajectory, and refinancing terms: those three factors will tell the Street whether the gap between the $61 share price and the $73 mean target has any realistic path to closing.